OR7E97P

Across TCGA pan-cancer cohorts, OR7E97P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated OR7E97P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR7E97P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E97P expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

STAD, UCEC, and LUSC are the cancer types where OR7E97P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.158	0.428	<.001	117	view →
UCEC	OS	Tertile	All	0.320	0.682	<.001	90	view →
LUSC	OS	Tertile	III,IV	0.001	0.684	<.001	72	view →
READ	OS	Tertile	II,III,IV	0.083	0.919	<.001	54	view →
BLCA	DFS	Tertile	All	0.171	0.517	<.001	54	view →
KIRP	OS	Tertile	All	0.216	0.904	<.001	45	view →
LAML	DFS	Tertile	All	0.325	0.597	.024	36	view →
TGCT	DFS	Tertile	II,III,IV	0.051	0.955	<.001	36	view →
KIRC	DFS	Tertile	IV	0.221	0.633	.001	36	view →
LGG	OS	Tertile	All	0.984	0.883	.014	21	view →
PCPG	DFS	Tertile	All	0.535	0.936	.005	18	view →
SARC	OS	Tertile	All	0.224	0.826	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

OR7E97P–STAD (DFS)

Open the STAD breakdown →